Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01782872 · ClinicalTrials.gov registry record · Phase 4
Analgesia After Total Shoulder Arthroplasty
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT01782872: Completed Phase 4 study, sponsored by Hospital for Special Surgery, New York.
NCT01782872 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 80 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01782872, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine which medication(s) should be included in the interscalene nerve block (an injection of local anesthetic \[numbing medicine\] near nerves in the shoulder) for patients undergoing total shoulder arthroplasty (shoulder replacement). The ideal nerve block would reduce pain after shoulder surgery without causing a great deal of muscle weakness.
Primary Outcome
Pain with movement at 24 hours from the nerve block (scale of 0-10; 0 = no pain, 10 = worst possible pain)
Interventions
- PROCEDURE Interscalene Block (ISB) - 0.375% Ropivacaine + additives
- PROCEDURE Interscalene Block (ISB) - 0.2% Ropivacaine + additives
- PROCEDURE Interscalene Block (ISB) - 0.1% Ropivacaine + additives
- PROCEDURE Interscalene Block (ISB) - Systemic Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-02 |
| Phase | Phase 4 |
What the finished NCT01782872 record still lists
NCT01782872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 4 interventions - of which Interscalene Block (ISB) - 0.375% Ropivacaine + additives is the first listed.
NCT01782872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01782872 about?
NCT01782872 is a clinical study titled "Analgesia After Total Shoulder Arthroplasty". The purpose of this study is to determine which medication(s) should be included in the interscalene nerve block (an injection of local anesthetic \[numbing medicine\] near nerves in the shoulder) for patients undergoing total shoulder arthroplasty (shoulder replacement). The ideal nerve block would...
What is the current status of trial NCT01782872?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2012-10. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01782872?
The interventions under investigation include: Interscalene Block (ISB) - 0.375% Ropivacaine + additives (PROCEDURE), Interscalene Block (ISB) - 0.2% Ropivacaine + additives (PROCEDURE), Interscalene Block (ISB) - 0.1% Ropivacaine + additives (PROCEDURE), Interscalene Block (ISB) - Systemic Control (PROCEDURE).
Who is sponsoring clinical trial NCT01782872?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01782872's enrollment target sits among peer trials
80 946th of 2000 higher than 1,021 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia